All lobbying filings

SIEMENS MEDICAL SOLUTIONS USA, INC

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $860,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 18

HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
HR 6197
Health Tech Investment Act
S 1399
Health Tech Investment Act
HR 4417
Mobile Cancer Screening Act
S 2927
Mobile Cancer Screening Act
S 1031
ROCR Value Based Program Act
HR 2120
ROCR Value Based Program Act
HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 2477
Portable Ultrasound Reimbursement Equity Act of 2025
S 1168
Portable Ultrasound Reimbursement Equity Act of 2025
HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
HRES 1333
Providing for consideration of the bill (H.R. 8646) making appropriations for Agriculture, Rural Development, Food and …
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
HR 8800
National Defense Authorization Act for Fiscal Year 2027
HRES 1398
Providing for consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activ…
S 4784
National Defense Authorization Act for Fiscal Year 2027

Lobbying activity 6

Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals.

Medicare/Medicaid

H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.

Trade (domestic/foreign)

Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.

Tariff (miscellaneous tariff bills)

Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.

Budget/Appropriations

H.R. 8646 / H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027.

Defense

H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.